Literature DB >> 23365711

Merosin-deficient congenital muscular dystrophy (MDCMD): a case report with MRI, MRS and DTI findings.

Janice J K Ip1, Peter K T Hui, M T Chau, Wendy W M Lam.   

Abstract

Congenital muscular dystrophy (CMD) comprises a heterogeneous group of disorders present at birth with muscle weakness, hypotonia and contractures. Congenital muscular dystrophy (CMD) comprises a heterogeneous group of disorders with muscle weakness, hypotonia and contractures present at birth. A particular subset of classic CMD is characterized by a complete absence of merosin. Merosin-deficient congenital muscular dystrophy (MDCMD) is a rare genetic disease involving the central and peripheral nervous system in the childhood. High signal intensities are often observed throughout the centrum semiovale, periventricular, and sub-cortical white matters on T2-weighted images in MRI brain in children with MDCMD. Apparent diffusion coefficient (ADC) map may reveal increased signal intensity and apparent diffusion coefficient values in the periventricular and deep white matters. These white matter findings, observed in late infancy, decrease in severity with age. The pathogenesis of these changes remains uncertain at present. In this article, we outline the specific MR imaging findings seen in a patient with documented MDCMD and also suggest the causes.

Entities:  

Keywords:  Congenital muscular dystrophy; Laminin; Magnetic resonance imaging; Merosin

Mesh:

Year:  2012        PMID: 23365711      PMCID: PMC3558266          DOI: 10.3941/jrcr.v6i8.997

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  11 in total

1.  Congenital muscular dystrophy with cerebral white matter hypodensity. Correlation of clinical features and merosin deficiency.

Authors:  U C Reed; S K Marie; M Vainzof; P B Salum; J A Levy; M Zatz; A Diament
Journal:  Brain Dev       Date:  1996 Jan-Feb       Impact factor: 1.961

2.  MR imaging findings in children with merosin-deficient congenital muscular dystrophy.

Authors:  P A Caro; M Scavina; E Hoffman; E Pegoraro; H G Marks
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

3.  Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.

Authors:  A Helbling-Leclerc; X Zhang; H Topaloglu; C Cruaud; F Tesson; J Weissenbach; F M Tomé; K Schwartz; M Fardeau; K Tryggvason
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

4.  Congenital muscular dystrophy of non-Fukuyama type with characteristic CT images.

Authors:  M Yoshioka; S Kuroki; H Mizue
Journal:  Brain Dev       Date:  1987       Impact factor: 1.961

5.  White matter abnormalities in congenital muscular dystrophy.

Authors:  Q H Leyten; F J Gabreëls; W O Renier; B G van Engelen; H J ter Laak; R C Sengers; H O Thijssen
Journal:  J Neurol Sci       Date:  1995-04       Impact factor: 3.181

6.  Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status.

Authors:  E Mercuri; F Muntoni; A Berardinelli; J Pennock; C Sewry; J Philpot; V Dubowitz
Journal:  Neuropediatrics       Date:  1995-02       Impact factor: 1.947

7.  Brain MR in Fukuyama congenital muscular dystrophy.

Authors:  N Aida; K Tamagawa; K Takada; A Yagishita; N Kobayashi; K Chikumaru; H Iwamoto
Journal:  AJNR Am J Neuroradiol       Date:  1996-04       Impact factor: 3.825

8.  Congenital muscular dystrophy: brain alterations in an unselected series of Western patients.

Authors:  C P Trevisan; C Carollo; P Segalla; C Angelini; P Drigo; R Giordano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

9.  Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients.

Authors:  E Pegoraro; H Marks; C A Garcia; T Crawford; P Mancias; A M Connolly; M Fanin; F Martinello; C P Trevisan; C Angelini; A Stella; M Scavina; R L Munk; S Servidei; C C Bönnemann; T Bertorini; G Acsadi; C E Thompson; D Gagnon; G Hoganson; V Carver; R A Zimmerman; E P Hoffman
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues.

Authors:  R Vuolteenaho; M Nissinen; K Sainio; M Byers; R Eddy; H Hirvonen; T B Shows; H Sariola; E Engvall; K Tryggvason
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  2 in total

1.  Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models.

Authors:  Andrea J Arreguin; Holly Colognato
Journal:  Front Mol Neurosci       Date:  2020-07-23       Impact factor: 5.639

2.  Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Afshin Khorrami; Pouya Goleij; Vahidreza Karamad; Elham Taheri; Behrouz Shadman; Parisa Emami; Gholamreza Jahangirzadeh; Saba Hajazimian; Alireza Isazadeh; Behzad Baradaran; Mansour Heidari
Journal:  J Clin Lab Anal       Date:  2021-09-16       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.